These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 3376818

  • 21. A grading system for the immunostaining of A, B and H blood group isoantigens in bladder carcinoma.
    Busch C, Malmström PU, Norlen BJ, Sällström J, Brodin T, Lundblad A.
    Anticancer Res; 1988; 8(1):81-7. PubMed ID: 3358642
    [Abstract] [Full Text] [Related]

  • 22. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A, Corominas J, Arango O.
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract] [Full Text] [Related]

  • 23. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M.
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [Abstract] [Full Text] [Related]

  • 24. T-antigen in normal and neoplastic urothelium.
    Limas C, Lange P.
    Cancer; 1986 Sep 15; 58(6):1236-45. PubMed ID: 3742450
    [Abstract] [Full Text] [Related]

  • 25. Blood group precursor T-antigen expression in human urinary bladder carcinoma.
    Coon JS, Weinstein RS, Summers JL.
    Am J Clin Pathol; 1982 Jun 15; 77(6):692-9. PubMed ID: 7091049
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA, Javadpour N, Worsham GF, O'Connell KJ.
    Urology; 1984 Apr 15; 23(4):348-51. PubMed ID: 6369713
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Expression of Thomsen-Friedenreich antigen (T-Ag) in gynecologic cancer tissues].
    Sakamoto Y, Kamada M, Shitsukawa K, Yasui T, Furumoto H, Mori K, Daitoh T, Irahara M, Kishi Y, Aono T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov 15; 39(11):1980-6. PubMed ID: 3429980
    [Abstract] [Full Text] [Related]

  • 32. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H, Zhao Z, Sun H.
    Zhonghua Wai Ke Za Zhi; 1996 Sep 15; 34(9):560-2. PubMed ID: 9594163
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
    Jones HL, Delahunt B, Bethwaite PB, Thornton A.
    Anticancer Res; 1997 Sep 15; 17(1B):685-7. PubMed ID: 9066602
    [Abstract] [Full Text] [Related]

  • 36. Expression and biosynthesis of ABH-related carbohydrate antigens in normal and pathologic human urothelium.
    Orntoft TF.
    APMIS Suppl; 1990 Sep 15; 17():1-34. PubMed ID: 1698403
    [No Abstract] [Full Text] [Related]

  • 37. [Tumor bladder antigen (TBA). A new method for the diagnosis and detection of recurrence of bladder cancer].
    Escaf Barmadah S, Martín Benito JL, Fernández Gómez JM, San Martín Blanco A, Pérez Gracia FJ, Rodríguez Martínez JJ.
    Arch Esp Urol; 1998 Mar 15; 51(2):129-36. PubMed ID: 9586309
    [Abstract] [Full Text] [Related]

  • 38. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H, Paulie S, Gustafsson B, Håkansson L, Lagerkvist M, Gustafson H, Ahlstrand C, Perlmann P.
    Anticancer Res; 1988 Mar 15; 8(3):443-9. PubMed ID: 3389746
    [Abstract] [Full Text] [Related]

  • 39. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G, Cavallini A, Piana P, Squintone L, Vottero M, Tizzani A.
    Minerva Urol Nefrol; 1992 Mar 15; 44(3):169-72. PubMed ID: 1492266
    [Abstract] [Full Text] [Related]

  • 40. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
    Piana P, Casetta G, Cavallini A, Piantino P, Tizzani A.
    Prog Clin Biol Res; 1991 Mar 15; 370():179-84. PubMed ID: 1924448
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.